Immunotherapy Linked to Hyperprogression of NSCLC and Other Cancers – Targeted Oncology
Immunotherapy Linked to Hyperprogression of NSCLC and Other CancersTargeted OncologyAwareness of hyperprogression—a rapid increase in tumor growth after initiation of immunotherapy—has been increasing since a 2016 French study first defined hyperprogre… Continue reading
